This is too often the reality for young men like 24-year-old Ryan Ballou, who was diagnosed more than 20 years ago with Duchenne muscular dystrophy (DMD) – a devastating disease that causes muscle breakdown and heart failure in boys and young men.
But because of Ryan’s indomitable spirit and researchers at The Ohio State University Wexner Medical Center, we are on the cusp of imagining a new future for DMD patients.
Ryan's Story
For more than 20 years, Ryan and his dad have traveled from Pittsburgh to Ohio State's Wexner Medical Center for treatment by neurologist Dr. John Kissel. Five years ago, Dr. Kissel referred Ryan to Ohio State’s Heart and Vascular Center, where a team of physician and researchers is collaborating on a revolutionary drug treatment for DMD that shows potential for delaying heart failure.Since Ryan started taking the medication more than five years ago, there has been no additional deterioration of his heart muscle. “I’ve been ahead of the curve,” Ryan shares. “I walk longer than most people and I still have a lot of strength in my arms.”
Ryan's success holds promise for thousands of men and their families affected by DMD.
Please support Ohio State's research on lifechanging treatment options for this debilitating disease and so many others. Your gift offers hope to patients like Ryan who look forward to active lives far beyond their mid-20s./
Learn more about new findings in Duchenne Muscular Dystrophy here.
How You Can Help
Donate Online
Make a gift online and help improve the lives of our patients.Donate by Mail
The James/Wexner Medical Center Development Officec/o The OSU Foundation
PO Box 710811
Columbus, OH 43271-0811